论文部分内容阅读
目的：：比较药师干预前后社区获得性肺炎( CAP)临床路径患者抗菌药物使用情况，规范合理用药，提高我院抗菌药物临床使用水平。方法：抽取呼吸科2013年(干预前)和2014年(干预后)进入临床路径的CAP患者各100例，比较两组抗菌药物费用、住院总费用、抗菌药物使用强度、住院时间、治疗效果等方面的指标。结果：干预前后两组患者在抗菌药物费用、住院总费用、抗菌药物使用强度、住院时间等方面差异均有统计学意义(P0.05)。结论：药师参与CAP临床路径患者抗菌药物治疗方案的审核干预后，规范了抗菌药物临床使用，降低了抗菌药物使用强度，降低了抗菌药物人均使用费用，缩短了住院天数等，提升了药师的价值。“,”Objective:To discuss the effect of pharmacist intervention on the use of antimicrobial agents in the clinical pathway of community-acquired pneumonia ( CAP) in our hospital to standardize the rational medication and promote the rational use of antimicro-bial agents. Methods:Totally 100 bacterial CAP patients in 2013 ( before the intervention) and 2014 ( after the intervention) in the pneumology department were studied. The antibacterial drug cost, total hospitalization cost, use intensity of antimicrobial drugs, hospi-talization time, therapeutic effects and so on in the two groups were observed during the treatment. Results: There were significant differences between the two groups in antibacterial drug cost, total hospitalization cost, use intensity of antimicrobial drugs, hospitaliza-tion time and so on, whereas there was no significant difference in the curative effect. Conclusion:After the pharmacist intervention, the application of antibiotics is more rational, the antibiotics use density and per capita cost are reduced, the hospitalization day is shortened and the value of pharmacists is also improved.